The Children’s Tumor Foundation (CTF) and the scientific journal PLOS ONE are collaborating on a new funding program in the area of neurofibromatosis (NF) research. The new initiative, called the Drug Discovery Initiative Registered Report (DDIRR) 2017 Awards, is a funder-publisher partnership to integrate the Registered Reports model in the grant application process.
We are thrilled to announce that Children’s Tumor Foundation President and Chief Scientific Officer Annette Bakker, PhD, has been announced as a recipient of a 2017 RARE Champion of Hope award.
The Children’s Tumor Foundation is pleased to announce the launch of the 2017 Young Investigator Award (YIA). Interested candidates can submit their letters of intent, also referred to as pre-applications, via CTF’s online application portal from Dec 12, 2016 to Jan 9, 2017. Initiated in 1985, the YIA is CTF’s longest running award program and provides two-year salary support to outstanding early career scientists worldwide who are interested in becoming independent investigators in neurofibromatosis.
Honorees include Bill Lerner, Dr. Brigitte C.Widemann, and Sarah Rodbell
On Wednesday, October 19, 2016, leading New York business leaders, together with friends, families and fundraisers, gathered at Current on Pier 59 for the annual Children’s Tumor Foundation New York Gala. This year’s theme asked everyone to “Imagine a World Without NF.”
The Fuller Albright Award is given in recognition of meritorious scientific accomplishment in the bone and mineral field to an ASBMR (American Society for Bone and Mineral Research) member who has not yet reached his or her 45th birthday. The 2016 ASBMR Fuller Albright Award was presented to Florent Elefteriou, PhD at the ASBMR 2016 Annual Meeting in Atlanta, Georgia, on September 18, 2016.